论文部分内容阅读
雷尼替丁是继西米替丁后又一新的H_2受体拮抗剂,疗效高、副作用少,是治疗消化性溃疡的常用药.我院在使用过程中发现白细胞(WBC)减少3例.现报道如下:1 病例介绍
Ranitidine is a new H 2 receptor antagonist after cimetidine, with high curative effect and few side effects, and is a commonly used medicine for the treatment of peptic ulcer.Our hospital found that white blood cells (WBC) decreased in 3 cases Now reported as follows: 1 case introduction